Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2012
05/30/2012CN101892200B Anti-H3N8 subtype equine influenza virus monoclonal antibody and application thereof
05/30/2012CN101824088B Inhibition of il-17 production
05/30/2012CN101798347B Monoclonal antibody for resisting high mobility group protein B1
05/30/2012CN101735309B Iridovirus antigen active polypeptide and application thereof
05/30/2012CN101724013B Method for separating and purifying immunoglobulin A, immunoglobulin G and lactoferrin from bovine colostrum in industrializing way
05/30/2012CN101643508B Single chain antibody of human anti-placenta growth factor
05/30/2012CN101643505B Nitrofuran compound and preparation method and application thereof
05/30/2012CN101516397B Treatment of multiple sclerosis (MS) with CAMPATH-1H
05/30/2012CN101386648B Neutralizing monoclonal antibodies against B type botulinum neurotoxin, preparation method and use thereof
05/30/2012CN101315378B Method and special ELISA reagent kit for detecting nitryl imidazole medicament
05/30/2012CN101250229B Alanine aminopherase monoclonal antibody and use thereof
05/30/2012CN101193915B Monoclonal antibodies and methods for their use in the detection of cervical disease
05/30/2012CN101184778B P-cadherin antibodies
05/30/2012CN101007850B Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
05/30/2012CN101002549B Transgenic non-human animals capable of producing heterologous antibodies
05/29/2012US8188249 Nucleic acid molecules encoding antibodies to M-CSF
05/29/2012US8188242 Chromatography purification of antibodies
05/29/2012US8188240 Tab molecules
05/29/2012US8188239 Multivalent carriers of bi-specific antibodies
05/29/2012US8188238 Recombinantly produced antibody
05/29/2012US8188237 Binding domain-immunoglobulin fusion proteins
05/29/2012US8188236 Eta-1 gene and methods for use
05/29/2012US8188235 Antibodies to IL-6 and their uses
05/29/2012US8188234 1D05 PCSK9 antagonists
05/29/2012US8188233 1B20 PCSK9 antagonists
05/29/2012US8188232 Compositions and methods for modulating lymphocyte activity
05/29/2012US8188231 Immunoglobulin with enhanced affinity for Fc gamma R's; immunotherapy; tissue targeted therapy; directed protein evolution
05/29/2012US8188228 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
05/29/2012US8188223 Serum albumin binding proteins
05/29/2012US8188221 Peptide homing to brain tumors
05/29/2012US8188220 Methods and compositions related to targeting wounds, regenerating tissue, and tumors
05/29/2012US8188051 Metadherin polypeptides, encoding nucleic acids and methods of use
05/29/2012US8188049 Peptides having activities of epidermal growth factor and its uses
05/29/2012US8188033 Anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity
05/29/2012US8187889 Using cytosolic serine hydroxymethyl transferase (cSHMT), T-box transcription factor 3 (Tbx3) and utrophin expression patterns as diagnostic/prognostic tool in detecting and prediciting outcomes associated cell proliferative disorders
05/29/2012US8187884 Method of enhancing homologous recombination of somatic cells and method of constructing specific antibody
05/29/2012US8187877 Chronic lymphocytic leukemia cell line
05/29/2012US8187873 Monoclonal antibody to soluble LOX-1
05/29/2012US8187828 Use of PAK inhibitor for the treatment of a joint disease
05/29/2012US8187604 Methods of treating with anti-factor D antibodies
05/29/2012US8187603 Antibodies to human IL-22
05/29/2012US8187601 Fibroblast growth factor receptor 3 (FGFR3) binding proteins
05/29/2012US8187600 Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses
05/29/2012US8187598 Methods of treating cancer by administering antibodies to CD200
05/29/2012US8187597 Combination therapy for the treatment of ocular neovascular disorders
05/29/2012US8187594 Transferrin receptor antibodies
05/29/2012US8187593 FcγRIIB specific antibodies and methods of use thereof
05/29/2012US8187587 Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme
05/29/2012CA2648099C System for targeted delivery of therapeutic agents
05/29/2012CA2616914C Egfr-binding antibody
05/29/2012CA2455403C Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
05/29/2012CA2449264C Method for generating diversity
05/29/2012CA2431321C Monoclonal antibodies to human immunodeficiency virus and uses thereof
05/29/2012CA2403327C Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
05/29/2012CA2395053C Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
05/29/2012CA2379388C Immunoglobulin fusion proteins
05/29/2012CA2361292C A novel chimeric protein for prevention and treatment of hiv infection
05/29/2012CA2343579C Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
05/29/2012CA2329148C Specific binding proteins for treating canine allergy
05/29/2012CA2268258C Single-chain multiple antigen-binding molecule, its preparation and use
05/29/2012CA2251604C Human hematopoietic stem and progenitor cell antigen and methods for its use
05/24/2012WO2012068540A2 Neutralizing anti-ccl20 antibodies
05/24/2012WO2012068317A2 Methods for producing recombinant proteins
05/24/2012WO2012068236A2 Novel fungal oxidoreductases
05/24/2012WO2012068073A2 Therapeutic and diagnostic applications targeting tnk-1
05/24/2012WO2012067176A1 Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii
05/24/2012WO2012066519A1 Luteinizing-hormone ligand and ligand-gonadotrophin complex
05/24/2012WO2012066481A1 New ethiological agent
05/24/2012WO2012066293A1 Therapeutic agent
05/24/2012WO2012066129A1 A collection and methods for its use
05/24/2012WO2012066089A1 Antibody with specificity for gm-csf (ii)
05/24/2012WO2012066071A1 Antibody with specificity for gm-csf (i)
05/24/2012WO2012066058A1 Agents and methods for treating diseases that correlate with bcma expression
05/24/2012WO2012065950A1 Silent fc variants of anti-cd40 antibodies
05/24/2012WO2012032181A3 Antibody derivatives
05/24/2012WO2012023053A3 Methods for the generation of multispecific and multivalent antibodies
05/24/2012WO2011150284A3 Removal of serine proteases by treatment with finely divided silicon dioxide
05/24/2012US20120129788 Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer
05/24/2012US20120129776 Bioactive peptides and method of using same
05/24/2012US20120129759 Protein surface remodeling
05/24/2012US20120129717 Collection and Methods For Its Use
05/24/2012US20120129710 Methods for producing members of specific binding pairs
05/24/2012US20120129702 Structure-Based Selection and Affinity Maturation of Antibody Library
05/24/2012US20120129200 Prodefensin-a6 assay method for the in vitro diagnosis of colorectal cancer
05/24/2012US20120129187 Diagnostical use of peroxiredoxin 4
05/24/2012US20120129168 Tumor marker and use thereof
05/24/2012US20120129167 Truncated cd20 protein, deltacd20
05/24/2012US20120128759 Method to inhibit airway hyperresponsiveness using aerosolized t cell receptor antibodies
05/24/2012US20120128717 Influenza virus vaccine composition and methods of use
05/24/2012US20120128707 Streptococcus pneumoniae proteins and nucleic acids
05/24/2012US20120128705 C6orf167 peptides and vaccines containing the same
05/24/2012US20120128698 Diagnosis and treatment of autoimmune demyelinating diseases
05/24/2012US20120128696 Methods for detecting and inhibiting angiogenesis
05/24/2012US20120128695 Teneurin c-terminal associated peptides (tcap) and methods and uses thereof
05/24/2012US20120128692 Human cytomegalovirus neutralizing antibodies and use thereof
05/24/2012US20120128691 Human cytomegalovirus neutralizing antibodies and use thereof
05/24/2012US20120128689 Anti-il-23 immunoglobulins
05/24/2012US20120128684 Conserved Hemagglutinin Epitope, Antibodies to the Epitope and Methods of Use
05/24/2012US20120128682 Apolipoprotein l- i variants and their use
05/24/2012US20120128680 Biomarker antibody and diagnosis device for detecting certain autoimmune diseases
1 ... 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 ... 1494